Clinuvel is on the verge of reporting a maiden profit, are continuing their rollout of Scenesse for EPP in Europe, and Scenesse was awarded fast track designation by the the FDA for EPP in the US in July.
Even without factoring in Vitiligo, the next 12-24 months are looking rosy.
VWAP of 5.9402 gives a more realistic picture of today's action.
Clinuvel is on the verge of reporting a maiden profit, are...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.90 |
Change
-0.200(1.42%) |
Mkt cap ! $695.8M | |||
| Open | High | Low | Value | Volume |
| $14.08 | $14.12 | $13.86 | $1.006M | 72.13K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 210 | $13.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.94 | 576 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| CUV (ASX) Chart |